Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
gptkb:N05AX14
|
| gptkbp:CASNumber |
162042-44-6
|
| gptkbp:developedBy |
gptkb:Servier_Laboratories
|
| gptkbp:hasMolecularFormula |
C17H19FN2O3
|
| gptkbp:hasSMILES |
CC1=CC2=C(C=C1)C(=O)N(C(=O)N2CC3=CC=CC=C3F)C
|
| gptkbp:hasUNII |
U6A868V6P8
|
| https://www.w3.org/2000/01/rdf-schema#label |
D08106
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
5-HT2C receptor antagonist
melatonin receptor agonist |
| gptkbp:molecularWeight |
243.34 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
82148 DB09238 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:Agomelatine
|
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:lidocaine
|
| gptkbp:bfsLayer |
6
|